Euglycemic Diabetic Ketoacidosis Secondary to SGLT2-inhibitor Use in Combination With a Ketogenic Diet

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are cardiorenal protective agents increasingly used in patients with diabetes. Cases of euglycemic diabetic ketoacidosis (euDKA) have been reported particularly among patients with type 1 diabetes. Our case is an example that highlights the role SGL...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Hester, Joi C, Zimmerman, Stacy, Nimmo, Teresa Allison, Cunningham, Wesley, Liu, Joshua, Sukpraprut-Braaten, Suporn, Pasquel, Francisco J
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Diabetes Mellitus and Glucose Metabolism
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089890/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.776
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars